$100B Pfizer Tie-Up Plan Puts Focus on U.S. Corporate Exodus

Apr 29, 2014

“"The lines drawn by the anti-inversion rules are reasonably clear, so if you're on the right side of the line, a transaction can certainly be crafted to benefit the company and can often be combined with subsequent transactions to access cash offshore.”

- Linda Z. Swartz, Chair of the Tax group at Cadwalader, commenting in Law360 on the benefits for companies pursuing inversion transactions.

Cadwalader News

ACI Summit on Controlled Substances: Regulation, Litigation and Enforcement

Jodi Avergun is speaking at this ACI event on January 30 in Washington, DC.

Cadwalader Subscription Center